Volume 144, Issue 1 pp. 136-138

Plectin, an unusual target antigen in bullous pemphigoid

E. Laffitte

E. Laffitte

Department of Dermatology, Hôpital Cantonal Universitaire, Rue Micheli du Crest 26 CH-1211 Geneva, Switzerland

Search for more papers by this author
B. Favre

B. Favre

Department of Dermatology, Hôpital Cantonal Universitaire, Rue Micheli du Crest 26 CH-1211 Geneva, Switzerland

Search for more papers by this author
L. Fontao

L. Fontao

Department of Dermatology, Hôpital Cantonal Universitaire, Rue Micheli du Crest 26 CH-1211 Geneva, Switzerland

Search for more papers by this author
S. Riou

S. Riou

Department of Dermatology, Hôpital Cantonal Universitaire, Rue Micheli du Crest 26 CH-1211 Geneva, Switzerland

Search for more papers by this author
F. Jaunin

F. Jaunin

Department of Dermatology, Hôpital Cantonal Universitaire, Rue Micheli du Crest 26 CH-1211 Geneva, Switzerland

Search for more papers by this author
K. Tamm

K. Tamm

Department of Dermatology, Hôpital Cantonal Universitaire, Rue Micheli du Crest 26 CH-1211 Geneva, Switzerland

Search for more papers by this author
J-H. Saurat

J-H. Saurat

Department of Dermatology, Hôpital Cantonal Universitaire, Rue Micheli du Crest 26 CH-1211 Geneva, Switzerland

Search for more papers by this author
L. Borradori

L. Borradori

Department of Dermatology, Hôpital Cantonal Universitaire, Rue Micheli du Crest 26 CH-1211 Geneva, Switzerland

Search for more papers by this author
First published: 07 July 2008
Citations: 19
L.Borradori. E-mail: [email protected]

Abstract

Background  Bullous pemphigoid (BP) is a blistering disease associated with autoantibodies directed against two components of hemidesmosomes, BP180 and BP230.

Objectives  To assess whether BP patients have autoantibodies targeting plectin, another hemidesmosomal component showing extensive homology to BP230.

Methods  Examination of sera from 16 patients with BP, using immunoprecipitation studies followed by immunoblotting.

Results  Serum of one of the 16 (6%) patients with BP contain autoantibodies binding to plectin, while no reactivity was found with sera from three control subjects. Sera from all 16 BP patients immunoprecipitated BP230 from extracts of biosynthetically radiolabelled human keratinocytes.

Conclusions  Our results indicate that sera from BP patients might contain autoantibodies binding to plectin. Although this protein and BP230 are closely sequence-related, the occurrence of autoantibodies binding to plectin is a rare phenomenon in BP.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.